Page 81 - Bse Nse

NTPC share gains 3% as Sebi okays NTPC Green Energy's Rs 10,000-cr IPO

The rise in NTPC share price came after the market regulator Securities and Exchnage Board of India (Sebi) approved NTPC Green Energy's initial public offering (IPO)

Cipla drops over 3% ahead of Q2FY25 results; know what analysts expect

Shares of Cipla dropped 3.55 per cent at Rs 1,450 per share on the BSE in Tuesday's intraday trade

Sharda Cropchem rallies 18% in 2 days on strong Q2 numbers; hits 52-wk high

The company's management said the company has seen volume growth across all regions, with Europe and NAFTA countries contributing the most

Gillette India soars 11% after posting strong quarterly earnings in Q2

Shares of Gillette India soared up to 11.54 per cent at Rs 9,537.70 per share on the BSE in Tuesday's intraday trade

DCX Systems at 5% upper limit as arm bags order from Lockheed Martin Global

The rise in DCX Systems share price came after the company announced that its wholly owned subsidiary, Raneal Advanced Systems, has received export orders from Lockheed Martin Global

Analysts offer mixed views on Sun Pharma's near term growth; revise target

Shares of Sun Pharmaceuticals, the biggest pharmaceutical company of India fell 1.71 per cent at Rs 1870 per share on the BSE after brokerages offered mixed reviews post Q2

Bharti Airtel slips 3% as Q2 nos. miss street expectations; ARPU at Rs 233

The drop in Bharti Airtel share price came after the company posted September quarter of financial year 2025 (Q2FY25) results, which fell short of Bloomberg estimates

Stocks to Watch, Oct 29: Airtel, Suzlon, Ajanta Pharma, Prestige Est, NTPC

Stocks to Watch, October 29, 2024: Bharti Airtel's revenue rose 8 per cent to Rs 41,473 crore from Rs 38,506 crore. Ebitda increased 11 per cent to Rs 21,846 crore

Nifty50 oversold on charts, may bounce in near term; check trading strategy

The Nifty 50 Index is currently oversold on the charts, with technical indicators such as RSI, MACD, and Stochastics all positioned in oversold zones

Key reasons why Sensex rose 1,100 pts, Nifty climbed 24,490 intraday today

After a challenging week for investors in Indian bourses, the markets finally turned positive on Monday, surging up to 1,137 points or 1.43 per cent and reclaiming the 80,000 mark at 80,539 levels

Shakti Pumps hits 5% upper circuit as profit grows multi-fold in Q2

Shares of Shakti Pumps were locked in a 5 per cent upper circuit at Rs 4,474.95 per share on the BSE in Monday's intraday deals

Max Estates zooms 7% after profit jumps 4,171% YoY in Q2FY25 results

Max Estates shares surged 7.1 per cent at Rs 586.90 per share on the BSE in Monday's intraday deals

Cipla Q2 Preview: Analysts expect lukewarm growth in sales, profit

Analysts expect Cipla to register a low single digit rise in the topline and bottomline, with margins being impacted by modest sales in the US and domestic formulations

Bandhan Bank jumps over 9% after profits soars 30% in Q2FY25 results

Bandhan Bank shares jumped 9.74 per cent at Rs 184.40 per share on the BSE in Monday's intraday deals

Shriram Finance rallies 7% on strong Q2 results; approves 1:5 stock split

The company's board has declared an interim dividend of 220 per cent, that is, Rs 22 per equity share for the financial year 2024-25

YES Bank stock soars 10% after green signals in Q2FY25 results; NII up 14%

YES Bank shares jumped 9.74 per cent at Rs 21.29 per share on the BSE

Stocks to Watch: ICICI Bank, IndiGo, Coal India, ITD Cement, Hindustan Zinc

Stocks to Watch: IndiGo posted a loss of Rs 986.7 crore in Q2, compared to a profit of Rs 188.9 crore in the previous year quarter.

Godrej Consumer gains 5% post Q2FY25 results; profit rises 13% YoY

FMCG major Godrej Consumer Products shares jumped 4.89 per cent at Rs 1,315.95 per share on the BSE

R R Kabel share price down 6% after Q2 PAT plunges 33% YoY

The fall in R R Kabel share price came after the company announced weak September quarter of financial year 2025 (Q2FY25) results.

Here's why Aarti Drugs shares fell 4% on October 25, more details here

The fall in Aarti Drugs share price came after the company reported a weak set of September quarter (Q2FY25) earnings.